LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | JW-7-24-1 | 10.0 | uM | LJP6 | 72 | hr | 929 | 864 | 3228 | 0.2678 | -0.0282 |
Hs 578T | Lapatinib | 10.0 | uM | LJP6 | 72 | hr | 929 | 2495 | 3228 | 0.7731 | 0.6814 |
Hs 578T | LDN-193189 | 10.0 | uM | LJP5 | 72 | hr | 929 | 515 | 3228 | 0.1597 | -0.1799 |
Hs 578T | Linifanib | 10.0 | uM | LJP6 | 72 | hr | 929 | 2426 | 3228 | 0.7516 | 0.6512 |
Hs 578T | Linsitinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 2646 | 3228 | 0.8197 | 0.7468 |
Hs 578T | Mitoxantrone | 10.0 | uM | LJP5 | 72 | hr | 929 | 442 | 3228 | 0.1369 | -0.2120 |
Hs 578T | Mitoxantrone | 10.0 | uM | LJP6 | 72 | hr | 929 | 466 | 3228 | 0.1446 | -0.2012 |
Hs 578T | MK2206 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1876 | 3228 | 0.5813 | 0.4120 |
Hs 578T | Neratinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 933 | 3228 | 0.2891 | 0.0018 |
Hs 578T | Nilotinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 1149 | 3228 | 0.3560 | 0.0957 |
Hs 578T | Nintedanib | 10.0 | uM | LJP6 | 72 | hr | 929 | 999 | 3228 | 0.3095 | 0.0303 |
Hs 578T | NU7441 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1186 | 3228 | 0.3674 | 0.1117 |
Hs 578T | Dactolisib | 10.0 | uM | LJP5 | 72 | hr | 929 | 1181 | 3228 | 0.3661 | 0.1098 |
Hs 578T | NVP-TAE684 | 10.0 | uM | LJP6 | 72 | hr | 929 | 815 | 3228 | 0.2525 | -0.0497 |
Hs 578T | Palbociclib | 10.0 | uM | LJP6 | 72 | hr | 929 | 1563 | 3228 | 0.4844 | 0.2760 |
Hs 578T | PD0325901 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1327 | 3228 | 0.4113 | 0.1733 |
Hs 578T | PD0325901 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1174 | 3228 | 0.3637 | 0.1065 |
Hs 578T | PD173074 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1530 | 3228 | 0.4740 | 0.2613 |
Hs 578T | PD184352 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1578 | 3228 | 0.4890 | 0.2825 |
Hs 578T | Pelitinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 718 | 3228 | 0.2226 | -0.0916 |
Hs 578T | PF431396 | 10.0 | uM | LJP5 | 72 | hr | 929 | 873 | 3228 | 0.2704 | -0.0245 |
Hs 578T | PF477736 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1036 | 3228 | 0.3209 | 0.0464 |
Hs 578T | PF562271 | 10.0 | uM | LJP6 | 72 | hr | 929 | 918 | 3228 | 0.2845 | -0.0047 |
Hs 578T | PHA-665752 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1974 | 3228 | 0.6115 | 0.4545 |
Hs 578T | PHA-793887 | 10.0 | uM | LJP6 | 72 | hr | 929 | 836 | 3228 | 0.2590 | -0.0406 |